Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-756-6 | CAS number: -
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 23 October 2012 to 06 November 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Aluminum, benzoate C16-18-fatty acids complexes
- EC Number:
- 303-385-6
- EC Name:
- Aluminum, benzoate C16-18-fatty acids complexes
- Cas Number:
- 94166-87-7
- Molecular formula:
- C23H37AlO5, C25H41AlO5
- IUPAC Name:
- Aluminum, benzoate C16-18-fatty acids complexes
- Reference substance name:
- 91466-87-7
- IUPAC Name:
- 91466-87-7
- Test material form:
- other: Solid
- Details on test material:
- - Physical state: Pale Yellow Solid
- Purity: Not applicable - UVCB
- Substance identity: Aluminum, benzoate C16-18-fatty acids complexes
- Batch number: 11074091 + Benzoic acid
- Carbon Content: 65.1%
- Analysis code: A118
- Date recieved: 07 June 2012
- Expiration date: 01 July 2013
- Storage of test material: Room temperature in the dark
Constituent 1
Constituent 2
- Specific details on test material used for the study:
- The substance is the source of the read-across.
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/Ca (CBA/CaOlaHsd)
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source:
Female CBA/Ca (CBA/CaOlaHsd) strain mice were supplied by Harlan UK Limited, Oxon, UK.
- Age at study initiation: At the start of the study the animals were eight to twelve weeks old.
- Weight at study initiation: At the start of the study the animals were in the weight range of 15 to 23g.
- Housing: The animals were individually housed in suspended solid-floor polypropylene cages furnished with softwood woodflakes.
- Diet (e.g. ad libitum): ad libitum (2014 Teklad Global Rodent diet supplied by Harlan UK Limited, Oxon, UK)
- Water (e.g. ad libitum): ad libitum.
- Acclimation period: At least five days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): The temperature was controlled to remain within the target ranges of 19 to 25 ºC.
- Humidity (%): The humidity was controlled to remain within the target ranges of 30 to 70%.
- Air changes (per hr): The rate of air exchange was approximately fifteen changes per hour.
- Photoperiod (hrs dark / hrs light): The lighting was controlled by a time switch to give twelve hours continuous light (06:00 to 18:00) and twelve hours darkness.
IN-LIFE DATES: From: Day 1 To: Day 6
Study design: in vivo (LLNA)
- Vehicle:
- propylene glycol
- Concentration:
- Each group was exposed to the test material at concentrations of 10%, 5% or 2.5% w/w in propylene glycol.
- No. of animals per dose:
- Groups of four mice were treated for each test item concentration plus vehicle control
- Details on study design:
- RANGE FINDING TESTS: Using available information regarding the systemic toxicity/irritancy potential of the test item, a preliminary screening test was performed using one mouse. The mouse was treated by daily application of 25 µL of the test item at a maximum attainable concentration (as a suspension) of 10% w/w in propylene glycol, to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The mouse was observed twice daily on Days 1, 2 and 3 and once daily on Days 4, 5 and 6. Local skin irritation was scored daily according to the scale included as Appendix 4. Any clinical signs of toxicity, if present, were also recorded. The bodyweight was recorded on Day 1 (prior to dosing) and on Day 6.
The thickness of each ear was measured using an Oditest micrometer (Dyer, PA), pre dose on Day 1, post dose on Day 3 and on Day 6. Any changes in the ear thickness were noted. Mean ear thickness changes were calculated between Days 1 and 3 and Days 1 and 6. A mean ear thickness increase of equal to or greater than 25% was considered to indicate excessive irritation and limited biological relevance to the endpoint of sensitisation.
- Lymph node proliferation response: No signs of systemic toxicity, visual local skin irritation or irritation indicated by an equal to or greater than 25% increase in mean ear thickness were noted.
Based on this information the dose levels selected for the main test were 10%, 5% and 2.5% w/w in propylene glycol.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay in the Mouse. The assay has undergone extensive inter-laboratory validation and has been shown to reliably detect test materials that are moderate to strong sensitisers.
- Criteria used to consider a positive response: The proliferation response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph node(dpm/node) and as the ratio of 3HTdR incorporation in lymph node cells of test nodes relative to that recorded for the control nodes (stimulation Index). The test material will be regarded as a sensitiser if at least one concentration of the test material results in a threefold or greater increase in 3HTdR incorporation compared to control values. Any test material failing to produce a threefold or greater increase in 3HTdR incorporation will be classified as a "non-sensitier".
TREATMENT PREPARATION AND ADMINISTRATION: For the purpose of the study, the test material was used at concentrations of 10%, 5% or 2.5% w/w in propylene glycol. This vehicle was chosen as it produced the highest concentration that was suitable for dosing. The test item was formulated within two hours of being applied to the test system. It is assumed that the formulation was stable for this duration. No analysis was conducted to determine the homogeneity, concentration or stability of the test item formulation. This is an exception with regard to GLP and has been reflected in the GLP compliance statement.
The preliminary screening test suggested that the test material would not produce systemic toxicity or excessive local irritation at the highest
suitable concentration. The mice were treated by daily application of 25 µl of the appropriate concentration of the test material to the dorsal surface
of each ear for three consecutive days (Days 1, 2 and 3). The test material formulation was administered using an automatic micropipette and spread over the dorsal surface of the ear using the tip of the pipette. A further group of four mice received the vehicle alone in the same manner
3H-Methyl Thymidine Administration: Five days following the first topical application of the test material (Day 6) all mice were injected via the tail vein with 250 µL of phosphate buffered saline (PBS) containing 3H-methyl thymidine (3HTdR: 80 µCi/mL, specific activity 2.0 Ci/mmol, ARC UK Ltd) giving a total of 20 µCi to each mouse. - Positive control substance(s):
- other: Phenylacetaldehyde
- Statistics:
- None provided.
Results and discussion
- Positive control results:
- One group of five animals was treated with 50 µL (25 µl per ear) of phenylacetaldehyde (>90%) as a solution in propylene glycol at a concentration of 2.5% v/v. A further control group of five animals was treated with propylene glycol alone.
The Stimulation Index expressed as the mean radioactive incorporation for the treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows:
Concentration % v/v in propylene glycol Stimulation Index (SI) Result
2.5 6.48 Positive
Phenylacetaldehyde (>90%) was considered to be a sensitiser under the conditions of the test.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 1.1
- Test group / Remarks:
- 2.5% in propylene glycol.
- Key result
- Parameter:
- SI
- Value:
- 0.83
- Test group / Remarks:
- 5% in propylene glycol.
- Key result
- Parameter:
- SI
- Value:
- 1.01
- Test group / Remarks:
- 10% in propylene glycol.
- Key result
- Parameter:
- SI
- Value:
- < 3
- Test group / Remarks:
- Undiluted test material.
Any other information on results incl. tables
Table 1 Clinical Observations, Bodyweight and Mortality Data – Preliminary Screening Test
Concentration (% w/w) in propylene glycol
Animal Number
Bodyweight (g)
Day
1
2
3
4
5
6
Day 1
Day 6
Pre-Dose
Post Dose
Pre-Dose
Post Dose
Pre-Dose
Post Dose
10
S-1
21
20
0
0
0
0
0
0
0
0
0
0= No signs of systemic toxicity
Table 2 Local Skin Irritation – Preliminary Screening Test
Concentration
(%w/w) in
propylene glycol
Animal Number
Local Skin Irritation
Day 1
Day 2
Day 3
Day 4
Day 5
Day 6
left
right
left
right
left
right
left
right
left
right
left
right
10
S-1
0
0
0
0
0
0
0
0
0
0
0
0
Table 3 Measurement of Ear Thicknessand Mean Ear Thickness Changes – Preliminary Screening Test
Concentration
(%w/w) in
propylene glycol
Animal Number
Ear Thickness Measurement (mm)
Day 1
Day 3
Day 6
pre‑dose
post dose
left
right
left
right
left
right
10
S-1
0.245
0.240
0.230
0.240
0.235
0.245
overall mean (mm)
0.243
0.235
0.240
overall mean ear thickness change (%)
na
-3.093
-1.031
na= Not applicable
Table 4 Disintegrations per Minute, Disintegrations per Minute/Node and Stimulation Index
Concentration
(%w/w) in
propylene glycol
dpm
dpm/Nodea
Stimulation Indexb
Result
Vehicle
5012.31
626.54
na
na
2.5
5528.98
691.12
1.10
Negative
5
4181.55
522.69
0.83
Negative
10
5039.56
629.95
1.01
Negative
dpm= Disintegrations per minut
a= Disintegrations per minute/node obtained by dividing the disintegrations per minute value by 8 (total number of lymph nodes)
b= Stimulation Index of 3.0 or greater indicates a positive result
na = Not applicable
Table 5 Individual Clinical Observations and Mortality Data
Concentration
(% w/w) propylene glycol
Animal Number
Day 1
Day 2
Day 3
Day 4
Day 5
Day 6
Pre-Dose
Post Dose
Pre-Dose
Post Dose
Pre-Dose
Post Dose
Vehicle
1-1
0
0
0
0
0
0
0
0
0
1-2
0
0
0
0
0
0
0
0
0
1-3
0
0
0
0
0
0
0
0
0
1-4
0
0
0
0
0
0
0
0
0
2.5
2-1
0
0
0
0
0
0
0
0
0
2-2
0
0
0
0
0
0
0
0
0
2-3
0
0
0
0
0
0
0
0
0
2-4
0
0
0
0
0
0
0
0
0
5
3-1
0
0
0
0
0
0
0
0
0
3-2
0
0
0
0
0
0
0
0
0
3-3
0
0
0
0
0
0
0
0
0
3-4
0
0
0
0
0
0
0
0
0
10
4-1
0
0
0
0
0
0
0
0
0
4-2
0
0
0
0
0
0
0
0
0
4-3
0
0
0
0
0
0
0
0
0
4-4
0
0
0
0
0
0
0
0
0
0= No signs of systemic toxicity
Table 6 Individual Bodyweights and Bodyweight Changes
Concentration
(% w/w) in
propylene glycol
Animal Number
Bodyweight (g)
Bodyweight Change (g)
Day 1
Day 6
Vehicle
1-1
22
21
-1
1-2
20
22
2
1-3
22
20
-2
1-4
17
18
1
2.5
2-1
18
19
1
2-2
20
20
0
2-3
18
19
1
2-4
21
22
1
5
3-1
19
18
-1
3-2
19
19
0
3-3
18
19
1
3-4
20
18
-2
10
4-1
20
22
2
4-2
20
20
0
4-3
18
21
3
4-4
19
19
0
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: other: Any test item failing to produce a threefold or greater increase in 3HTdR incorporation will be classified as a "non sensitiser".
- Conclusions:
- The test material, aluminum, benzoate C16-18-fatty acids complexes was considered to be a non-sensitiser under the conditions of the test.
- Executive summary:
Introduction
A study was performed to assess the skin sensitisation potential of the test material in the CBA/Ca strain mouse following topical application to the dorsal surface of the ear. The skin sensitisation potential was assessed in a proprietary, GLP-compliant experimental study (Harlan 2013) following OECD Guideline for the Testing of Chemicals No. 429 "Skin Sensitisation: Local Lymph Node Assay"(adopted 22 July 2010) and Method B42 Skin Sensitisation (Local Lymph Node Assay) of Commission Regulation (EC) No. 440/2008.The study is considered reliable and relevant for use for this endpoint.
Methods.
Following a preliminary screening test in which no clinical signs of toxicity were noted at a concentration of 10% w/w, this concentration was selected as the highest dose investigated in the main test of the Local Lymph Node Assay. Three groups, each of four animals, were treated with 50 µL (25 µL per ear) of the test material as a suspension in propylene glycol at concentrations of10%, 5% or 2.5% w/w. A further group of four animals was treated with propylene glycol alone.
Results.
The Stimulation Index expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows:
Concentration (%w/w) in propylene glycol
Stimulation Index
Result
2.5
1.10
Negative
5
0.83
Negative
10
1.01
Negative
Conclusion.
The test material, aluminum, benzoate C16-18-fatty acids complexes was considered to be a non-sensitiser under the conditions of the test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
